Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04589832
Title Study of PAC-1 and Entrectinib for Patients With Metastatic Uveal Melanoma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Arkadiusz Z. Dudek, MD
Indications

uveal melanoma

Therapies

Entrectinib + PAC-1

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.